Emil Kakkis - President & CEO, Ultragenyx Pharmaceutical Inc

As of May 10, 2021


Emil Kakkis Net Worth

  • Net worth is estimated to be at least $84.56M
  • Owns at least 2,855,793 units of Ultragenyx Pharmaceutical Inc stock
  • Sold an estimated value of $24.19M in the last 4 years at Ultragenyx Pharmaceutical Inc

Emil Kakkis Trading

  • Largest purchase of shares was 7,500 units , worth over $393.92K on August 29, 2017
  • Largest sale of shares was 46,342 units , worth over $6.58M on March 3, 2021
  • In total has made about 28 transactions over 4 years
  • Usually trades in May, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Emil Kakkis Mailing Address

  • Mailing address is C/o Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 CA

Ultragenyx Pharmaceutical Inc Insider Trading

  • The most recent transaction was 7,336 units sold on September 9, 2021 by Karah Parschauer worth over $738.37K
  • In the last 7 years, insiders at Ultragenyx Pharmaceutical Inc sold an estimated value of $113.8M and bought an estimated value of $17.54M
  • The most active traders are Shalini Sharp, EVP,  Emil Kakkis, President & CEO,  and Alan Theodore Huizenga, SVP
  • Insider trading is most common in June, with the busiest year in 2020

Ultragenyx Pharmaceutical Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1